IDEXX Laboratories, Inc. - Common Stock (IDXX)

Stephen Weiss of Short Hills Capital Partners recommended buying Meta Platforms, which is down almost 20% from the high.

Investors were barking for some shares thanks to a better-than-expected earnings report.

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.

Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.

Wall Street opened the week on a mixed note on Monday.

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Idexx Laboratories catapulted to a record high Monday after the vet diagnostics outlet beat quarterly forecasts.

Idexx stock gains after Q3 earnings and revenue beat expectations, driven by strong CAG growth and raised 2025 earnings and sales guidance.

IDEXX (IDXX) Q3 2025 Earnings Call Transcript

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

IDEXX Labs Q3 2025 results beat estimates with strong revenue and EPS growth. The veterinary diagnostics leader also raised its full-year outlook.

Key stocks to watch include Williams Companies, Spirit AeroSystems, Goodyear Tire & Rubber, IDEXX Laboratories, and ON Semiconductor

Parsippany, N.J. – October 9, 2025 – Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today declared a quarterly dividend of $0.50 per share for the fourth quarter of 2025. This proactive announcement, made well in advance of the payment date, underscores the company's consistent commitment to shareholder

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

IDEXX Laboratories excels with strong revenue growth, a 50% ROIC, and high-quality earnings, making it a top-tier quality investment candidate.

IDEXX Laboratories's (NYSE: IDXX) short interest as a percent of float has risen 3.64% since its last report. According to exchange reported data, there are now 2.12 million shares sold short, which is 3.42% of all regular shares that are available for trading.